Issue link: https://www.e-digitaleditions.com/i/401821
32 | Bulletin vol. 28 no. 2 References Alzheimer's Association. (2012). Alzheimer's Disease Facts and Figures. Alzheimer's & Dementia, 8, 1-72. Booiji, B. B., Lindahl, T., Wetterberg, P., Skaane, N. V., Saebo, S., Feten, G., Rye, P. D., Kristiansen, L. I., Hagen, N., Jensen, M., Bardsen, K., Winblad, B., Sharma, P., Lonneborg, A. (2011). A gene expression pattern in blood for the early detection of Alzheimer's disease. Journal of Alzheimer's Disease, 23(1), 109-119. Buerger, K., Ernst, A., Ewers, M., Uspenskaya, O., Omerovic, M., Morgen- thaler, N. G., Knauer, K., Bergmann, A., & Hampel, H. (2009). Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of mid- regional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio. Biological Psychiatry, 65(11), 979-984. Burnham, S. C., Faux, N. G., Wilson, W., Laws, S. M., Ames, D., Bedo, J., Bush, A. L., Doecke, J. D., Ellis, K. A., Head, R., Jones, G., Kiiveri, H., Martins, R. N., Rembach, A., Rowe, C. C., Salvado, O., Macaulay, S. L., Masters, C. L., & Villemagne, V. L.; Alzheimer's Disease Neuroimaging Initiative; Australian Imaging, Biomarkers and Lifestyle Study Research Group. (2014). A blood- based predictor for neocortical Aβ burden in Alzheimer's disease: Results from the AIBL study. Molecular Psychiatry, 19(4), 519-526. Doecke, J. D., Laws, S. M., Faux, N. G., Wilson, W., Burnham, S. C., Lam, C. P., Mondal, A., Bedo, J., Bush, A. I., Brown, B., De Ruyck, K., Ellis, K. A., Fowler, C., Gupta, V. B., Head, R., Macaulay, S. L., Pertile, K., Rowe, C. C., Rembach, A., Rodrigues, M., Rumble, R., Szoeke, C., Taddei, T., Trounson, B., Ames, D., Masters, C. L., & Martins, R. N.; Alzheimer's Disease Neuroimaging Initia- tive; Australian Imaging, Biomarker and Lifestyle Research Group. (2012). Blood-based protein biomarkers for the diagnosis of Alzheimer's disease. Archives of Neurology, 69(10), 1318-1325. Edwards, M., Balldin, V. H., Hall, J., & O'Bryant, S. E. (2014a, in press). Com- bining select neuropsychological assessment with blood-based biomark- ers to detect mild Alzheimer's disease: A Molecular Neuropsychology approach. Journal of Alzheimer's Disease. Edwards, M., Hynan L.S., Suen E., Smith, J.P., Huebinger, R., Cullum, C.M., Lacritz, L., Reisch, J.S., Rosenberg, R., & O'Bryant, S. (2014b). Molecular Neuropsychology for the Detection of Amnestic and Non-Amnestic Mild Cognitive Impairment. Poster to be presented at the 2014 meeting of the National Academy of Neuropsychology in Fajardo, Puerto Rico. Henriksen, K., O'Bryant, S. E., Hampel, H., Trojanowski, J. Q., Montine, T. J., Jeromin, A., Blennow, K., Lonnebrog, A., Wyss-Coray, T., Soares, H., Bazenet, C., Sjogren, M., Hu, W., Lovestone, S., Karsdal, M. A., & Weiner, M. W.; Blood-Based Biomarker Interest Group. (2014). The future of blood-based biomarkers for Alzheimer's disease. Alzheimer's and Dementia, 10(1), 115- 131. Hye, A., Riddoch-Contreras, J., Baird, A. L., Ashton, N.J., Bazenet, C., Leung, R., Westman, E., Simmons, A., Dobson, R., Sattlecker, M., Lupton, M., Lun- non, K., Keohane, A., Ward, M., Pike, I., Dieter Zucht, H., Pepin, D., Zheng, W., Tunnicliffe, A., Richardson, J., Gauthier, S., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., & Lovestone, S. (2014, in press). Plasma proteins predict conversion to dementia from prodromal disease. Al- zheimer's & Dementia, 1-9. Kiddle, S. J., Sattlecker, M., Proitsi, P., Simmons, A., Westman, E., Bazenet, C., Nelson, S. K., Williams, S., Hodges, A., Johnston, C., Soininen, H., Klosze- wska, I., Mecocci, P., Tsolaki, M., Vellas, B., Newhouse, S., Lovestone, S., & Dobson, R. J. B. (2014). Candidate blood proteome markers of Alzheimer's disease onset and progression: A systematic review and replication study. Journal of Alzheimer's Disease, 38(3), 515-531. Laske, C., Leyhe, T., Stransky, E., Hoffmann, N., Fallgatter, A. J., & Dietzsch, J. (2011). Identification of a blood-based biomarker panel for classification of Alzheimer's disease. International Journal of Neuropsychopharmacology, 14(9), 1147-1155. Laske, C., Schmohl, M., Leyhe, T., Stransky, E., Maetzler, W., Berg, D., Fallgat- ter, A. J., Joos, T., & Dietzsch, J. (2013). Immune profiling in blood identified sTNF-R1 performing comparably well as biomarker panels for classifica- tion of Alzheimer's disease patients. Journal of Alzheimer's Disease, 34(2), 367-375. Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., Mac Arthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., & Federoff, H. J. (2014). Plasma phospholipids identify antecedent memory impairment in older adults. Nature Medicine, 20(4), 415-418. Nagele, E., Han, M., DeMarshall, C., Belinka, B., & Nagele, R. (2011). Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera. PLoS One, 6, e23112. O'Bryant, S. E., Xiao, G., Zhang, F., Edwards, M., German, D. C., Yin, X., Como, T., Reisch, J., Huebinger, H. M., Graff-Radford, N., Dickson, D., Barber, R. C., Hall, J., O'Suilleabhain, P. & Grammas, P. (2014a, in press). Validation of a serum screen for Alzheimer's disease across assay platforms, species and tissues. Journal of Alzheimer's Disease. O'Bryant, S.E., Gupta, V., Henriksen, K., Edwards, M., Jeromin, A., Lista, S., Bazenet, C., Soares, H., Lovestone, S., Hampel, H., Montine, T., Blennow, K., Foround, T., Carrillo, M., Graff-Radford, N., Laske, C., Breteler, M., Shaw, L., Trojanowski, J.Q., Schupf, N., Rissman, R.A., Fagan, A.M., Oberoi, P., Umek, R., Weiner, M.W., Grammas, P., Posner, H., & Martins, R. for the STAR-B and BBBIG working groups (2014b, in press) Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research. Alzheimer's & Dementia. O'Bryant, S. E., Xiao, G., Barber, R., Huebinger, R., Wilhelmsen, K., Edwards, M., Graff-Radford, N., Doody, R., Diaz-Arrastia, R.; Texas Alzheimer's Re- search & Care Consortium; Alzheimer's Disease Neuroimaging Initiative. (2011a). A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings form TARC and ADNI. PLoS One, 6(12), e28092. O'Bryant, S. E., Xiao, G., Barber, R., Reisch, J., Doody, R., Fairchild, T., Adams, P., Waring, S., Diaz-Arrastia, R.; Texas Alzehimer's Research Consortium. (2010). A serum protein-based algorithm for the detection of Alzheimer disease. Archives of Neurology, 67(9), 1077-1081. O'Bryant, S., Xiao, G., Barber, R., Reisch, J., Hall, J., Cullum, C.M., Doody, R., Fairchild, T., Adams. P., Wilhelmsen, K. & Diaz-Arrastia, R. (2011b). A Blood- Based Algorithm for the Detection of Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders, 32(1), 55-62. O'Bryant, S. E., Xiao, G., Edwards, M., Devous, M., Gupta, V. A., Martins, R., Zhang, F., & Barber, R.; Texas Alzheimer's Research and Care Consortium (TARCC). (2013b). Biomarkers of Alzheimer's disease among Mexican Americans. Journal of Alzheimer's Disease, 34(4), 841-849. Ray, S., Britschqi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., Kaye, J. A., Leszek, J., Miller, B. L., Minthon, L., Quinn, J. F., Rabinovici, G. D., Robin- son, W. H., Sabbagh, M. N., So, Y. T., Sparks, D. L., Tabaton, M., Tinklenberg, J., Yesavage, J. A., Tibshirani, R., & Wyss-Coray, T. (2007). Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nature Medicine,13(11),1359-1362. Reddy, M. M., Wilson, R., Wilson, J., Connell, S., Gocke, A., Hynan, L., Ger- man, D., & Kodadek, T. (2011). Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening. Cell, 144(1), 132-142. Schneider, P., Hampel, H., & Buerger, K. (2009). Biological marker candi- dates of alzheimer's disease in blood, plasma, and serum. CNS Neurosci- ence and Therapeutics, 15(4), 358-374. Snyder, H. M., Carrillo, M. C., Grodstein, F., Henriksen, K., Jeromin, A., Lovestone, S., Mielke, M. M., O'Bryant, S., Sarasa, M., Sjogren, M., Soares, H., Teeling, J., Trushina, E., Ward, M., West, T., Bain, L. J., Shineman, D. W., Weiner, M., & Fillit, H. M. (2014). Developing novel blood-based biomark- ers for Alzheimer's disease. Alzheimer's & Dementia, 10(1), 109-114. Soares, H. D., Chen, Y., Sabbagh, M., Roher, A., Schrijvers, E., & Breteler, M. (2009). Identifying early markers of ALzhiemer's disease using quantita- tive multiplex proteomic immunoassay panels. Annuals of the New York Academy of Science, 1180, 56-76. Soares, H. D., & Lovestone, S. (2014, in press). Biomarker utility in Alzheim- er's disease clinical trials. Drug Discovery Today: Therapeutic Strategies.